Edition:
India

Horizon Pharma Plc Announces Agreement To License Pre-Clinical Uricase Derivative From Medimmune


Monday, 8 Jan 2018 

Jan 8 (Reuters) - Horizon Pharma Plc ::HORIZON PHARMA PLC ANNOUNCES AGREEMENT TO LICENSE PRE-CLINICAL URICASE DERIVATIVE (MEDI4945) FROM MEDIMMUNE.HORIZON PHARMA PLC - WILL PROVIDE MEDIMMUNE AN UPFRONT CASH PAYMENT AND FUTURE PAYMENTS CONTINGENT ON MEDI4945 DEVELOPMENT AND SALES MILESTONES. 

Company Quote

24.53
-0.39 -1.57%
22 Apr 2019